EP400NL is involved in PD-L1 gene activation by forming a transcriptional coactivator complex
dc.citation.issue | 1 | |
dc.citation.volume | 1866 | |
dc.contributor.author | Li Z | |
dc.contributor.author | Kim H | |
dc.contributor.author | Kim J | |
dc.contributor.author | Park JH | |
dc.coverage.spatial | Netherlands | |
dc.date.accessioned | 2024-09-12T03:06:11Z | |
dc.date.available | 2024-09-12T03:06:11Z | |
dc.date.issued | 2023-03 | |
dc.description.abstract | EP400 is an ATP-dependent chromatin remodelling enzyme that regulates DNA double-strand break repair and transcription, including cMyc-dependent gene expression. We previously showed that the N-terminal domain of EP400 increases the efficacy of chemotherapeutic drugs against cancer cells. As the EP400 N-terminal-Like (EP400NL) gene resides next to the EP400 gene locus, this prompted us to investigate whether EP400NL plays a similar role in transcriptional regulation to the full-length EP400 protein. We found that EP400NL forms a human NuA4-like chromatin remodelling complex that lacks both the TIP60 histone acetyltransferase and EP400 ATPase. However, this EP400NL complex displays H2A.Z deposition activity on a chromatin template comparable to the human NuA4 complex, suggesting another associated ATPase such as BRG1 or RuvBL1/RuvBL2 catalyses the reaction. We demonstrated that the transcriptional coactivator function of EP400NL is required for serum and IFNγ-induced PD-L1 gene activation. Furthermore, transcriptome analysis indicates that EP400NL contributes to cMyc-responsive mitochondrial biogenesis. Taken together, our studies show that EP400NL plays a role as a transcription coactivator of PD-L1 gene regulation and provides a potential target to modulate cMyc functions in cancer therapy. | |
dc.description.confidential | false | |
dc.edition.edition | March 2023 | |
dc.format.pagination | 194889- | |
dc.identifier.author-url | https://www.ncbi.nlm.nih.gov/pubmed/36328277 | |
dc.identifier.citation | Li Z, Kim H, Kim J, Park JH. (2023). EP400NL is involved in PD-L1 gene activation by forming a transcriptional coactivator complex.. Biochim Biophys Acta Gene Regul Mech. 1866. 1. (pp. 194889-). | |
dc.identifier.doi | 10.1016/j.bbagrm.2022.194889 | |
dc.identifier.eissn | 1876-4320 | |
dc.identifier.elements-type | journal-article | |
dc.identifier.issn | 1874-9399 | |
dc.identifier.number | 194889 | |
dc.identifier.pii | S1874-9399(22)00104-3 | |
dc.identifier.uri | https://mro.massey.ac.nz/handle/10179/71449 | |
dc.language | eng | |
dc.publisher | Elsevier B V | |
dc.publisher.uri | https://www.sciencedirect.com/science/article/pii/S1874939922001043 | |
dc.relation.isPartOf | Biochim Biophys Acta Gene Regul Mech | |
dc.rights | (c) 2022 The Author/s | |
dc.rights | CC BY 4.0 | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Cancer | |
dc.subject | Chromatin remodelling | |
dc.subject | Epigenetic | |
dc.subject | H2A.Z | |
dc.subject | PD-L1 | |
dc.subject | cMyc | |
dc.subject | Humans | |
dc.subject | Adenosine Triphosphatases | |
dc.subject | ATPases Associated with Diverse Cellular Activities | |
dc.subject | B7-H1 Antigen | |
dc.subject | Carrier Proteins | |
dc.subject | DNA Helicases | |
dc.subject | Histones | |
dc.subject | Transcription Factors | |
dc.subject | Transcriptional Activation | |
dc.title | EP400NL is involved in PD-L1 gene activation by forming a transcriptional coactivator complex | |
dc.type | Journal article | |
pubs.elements-id | 457982 | |
pubs.organisational-group | Other |
Files
License bundle
1 - 1 of 1